TrialClinical pharmacokinetics2007

The absolute oral bioavailability and population-based pharmacokinetic modelling of a novel dipeptidylpeptidase-IV inhibitor, vildagliptin, in healthy volunteers.

Yan-Ling He et al.PubMed ↗Publisher ↗

No numbers read from the abstract.